These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 24073656)
1. Relapsing lymphomatoid papulosis after allogenic bone-marrow transplant. Miquel J; Vourc'h-Jourdain M; Thomas C; Cassagnau E; Stalder JF; Barbarot S Clin Exp Dermatol; 2013 Oct; 38(7):741-4. PubMed ID: 24073656 [TBL] [Abstract][Full Text] [Related]
2. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414 [TBL] [Abstract][Full Text] [Related]
3. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration. Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462 [TBL] [Abstract][Full Text] [Related]
4. A case of systemic anaplastic large cell lymphoma with 'Hodgkin-like' appearance and skin involvement mimicking lymphomatoid papulosis. Kiniwa Y; Ide Y; Fukushima M; Asano N; Saida T J Cutan Pathol; 2011 Jan; 38(1):38-42. PubMed ID: 20002236 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea. Kim YC; Yang WI; Lee MG; Kim SN; Cho KH; Lee SJ; Lee MW; Koh JK Int J Dermatol; 2006 Nov; 45(11):1312-6. PubMed ID: 17076712 [TBL] [Abstract][Full Text] [Related]
6. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Herbst H; Sander C; Tronnier M; Kutzner H; Hügel H; Kaudewitz P Br J Dermatol; 1997 Nov; 137(5):680-6. PubMed ID: 9415224 [TBL] [Abstract][Full Text] [Related]
7. CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis. Aoki M; Niimi Y; Takezaki S; Azuma A; Seike M; Kawana S Br J Dermatol; 2001 Jul; 145(1):123-6. PubMed ID: 11453920 [TBL] [Abstract][Full Text] [Related]
8. Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma. A report of two cases and a review of the literature. McCarty MJ; Vukelja SJ; Sausville EA; Perry JJ; James WD; Jaffe ES; Weiss RB Cancer; 1994 Dec; 74(11):3051-8. PubMed ID: 7954268 [TBL] [Abstract][Full Text] [Related]
9. Nodal anaplastic large-cell lymphoma ALK-1- with CD30+ cutaneous lymphoproliferation treated with mistletoe: spontaneous remission or treatment response? Kameda G; Kempf W; Oschlies I; Michael K; Seifert G; Längler A Klin Padiatr; 2011 Nov; 223(6):364-7. PubMed ID: 22052633 [TBL] [Abstract][Full Text] [Related]
10. Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution. Xerri L; Adélaïde J; Avenin M; Guille A; Taix S; Bonnet N; Carbuccia N; Garnier S; Mescam L; Murati A; Chaffanet M; Coso D; Bouabdallah R; Bertucci F; Birnbaum D Histopathology; 2019 Mar; 74(4):654-662. PubMed ID: 30393995 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Benner MF; Jansen PM; Meijer CJ; Willemze R Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236 [TBL] [Abstract][Full Text] [Related]
12. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders. Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894 [TBL] [Abstract][Full Text] [Related]
13. Lymphomatoid papulosis in children: a series of 25 cases. Miquel J; Fraitag S; Hamel-Teillac D; Molina T; Brousse N; de Prost Y; Bodemer C Br J Dermatol; 2014 Nov; 171(5):1138-46. PubMed ID: 24749749 [TBL] [Abstract][Full Text] [Related]
14. Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG). Blanchard M; Morren MA; Busschots AM; Hauben E; Alberti-Violetti S; Berti E; Avallone G; Tavoletti G; Panzone M; Quaglino P; Colonna C; Melchers RC; Vermeer MH; Gniadecki R; Mitteldorf C; Gosmann J; Stadler R; Jonak C; Oren-Shabtai M; Hodak E; Friedland R; Gordon E; Geskin LJ; Scarisbrick JJ; Mayo Martínez F; Noguera Morel L; Pehr K; Amarov B; Faouzi M; Nicolay JP; Kempf W; Blanchard G; Guenova E Br J Dermatol; 2024 Jul; 191(2):233-242. PubMed ID: 38595050 [TBL] [Abstract][Full Text] [Related]
15. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma. Sanka RK; Eagle RC; Wojno TH; Neufeld KR; Grossniklaus HE Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey. Baykal C; Kılıç Sayar S; Yazganoğlu KD; Büyükbabani N Turk J Haematol; 2021 Feb; 38(1):49-56. PubMed ID: 33389922 [TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis. Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703 [TBL] [Abstract][Full Text] [Related]
18. Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl. Ju E; Adigun C; Dunphy C; Gold S; Morrell DS Pediatr Dermatol; 2012; 29(4):498-503. PubMed ID: 21967522 [TBL] [Abstract][Full Text] [Related]
19. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates. De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140 [TBL] [Abstract][Full Text] [Related]
20. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin. Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]